Dual targeted therapy with anakinra and Janus kinase inhibition in multidrug-refractory adult-onset still’s disease: a case report with nearly 7 years of follow-up
Dual targeted therapy with anakinra and Janus kinase inhibition in multidrug-refractory adult-onset still’s disease: a case report with nearly 7 years of follow-up. // EULAR Rheumatology Open. – URL: https://www.sciencedirect.com/science/article/pii/S305070812600176X?dgcid=rss_sd_all
Dual targeted therapy with anakinra and Janus kinase inhibition in multidrug-refractory adult-onset still’s disease: a case report with nearly 7 years of follow-up. EULAR Rheumatology Open. https://www.sciencedirect.com/science/article/pii/S305070812600176X?dgcid=rss_sd_all
“Dual targeted therapy with anakinra and Janus kinase inhibition in multidrug-refractory adult-onset still’s disease: a case report with nearly 7 years of follow-up.” EULAR Rheumatology Open.
@article{article100086,
title = {Dual targeted therapy with anakinra and Janus kinase inhibition in multidrug-refractory adult-onset still’s disease: a case report with nearly 7 years of follow-up},
journal = {EULAR Rheumatology Open},
url = {https://www.sciencedirect.com/science/article/pii/S305070812600176X?dgcid=rss_sd_all}
}